We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIOCARE CORP

BioCare Corporation manufactures and markets medical devices such as electrolyte analyzer, urine analyzer, hospital-g... read more Featured Products: More products

Download Mobile App




Fully Open Automated Slide Staining Instrument Designed for Robust Antibody Staining

By LabMedica International staff writers
Posted on 07 Dec 2023

An advanced staining instrument with state-of-the-art upgrades has been designed for ultimate flexibility and robust antibody staining with rich features for enhanced laboratory usability. More...

Biocare Medical (Pacheco, CA, USA) has introduced the intelliPATH+ advanced staining instrument, a newly upgraded system featuring the latest technological advancements. This fully open system allows for continuous random access along with immediate STAT capabilities, enhancing the workflow significantly. It is particularly efficient in immunohistochemistry (IHC) staining, providing increased speed, superior quality, and reduced waste. The intelliPATH+ is tailor-made for lab professionals who value the dependability of automated processes but require flexibility for specific needs. It features customizable protocols for each of its 50 slide positions, promoting both precision and efficiency.

The intelliPATH+ boasts a redesigned, scalable user interface that makes laboratory workflow more efficient. This user-friendly interface allows easy navigation with options for pre-set protocols or custom creation, including adjustable dispense volumes from 100µl to 600µl across three different zones. This customization ensures an efficient and personalized staining experience. The system meticulously controls every aspect of the staining process. When combined with Biocare Medical’s latest ARC decloaking chamber, it delivers robust, reproducible, and vivid staining results.

The ARC, specifically designed for Heat-Induced Epitope Retrieval (HIER) and compliant with in vitro diagnostic (IVD) standards, is indispensable for high-quality IHC and in situ hybridization (ISH) staining. It can hold up to 72 standard slides or 27 double-wide slides, offering a broad temperature range from 60°C to 121°C. This capability makes the ARC a crucial tool for both clinical and research settings, ensuring accurate and consistent results. The intelliPATH+, now labeled for IVD use, is available for purchase in the United States and selected international markets.

Related Links:
Biocare Medical


New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Hematology Consumables
Bioblood Devices
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings point to the feasibility of a quick, noninvasive urine-based approach to support earlier decision-making in multiple psychiatric conditions (photo credit: Shutterstock)

Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

Delays in diagnosing serious psychiatric conditions can leave patients without timely support and complicate treatment planning. For bipolar disorder, average time to diagnosis can exceed nine years, and... Read more

Molecular Diagnostics

view channel
Image: The schematic diagram links key MASLD, MASH, and MASLD-HCC molecular drivers to emerging multi‑omics biomarkers and therapeutic modalities, highlighting the current barriers in clinical translation and strategic solutions aimed at refined risk stratification and personalized medicine (Photo courtesy of ©Science China Press)

Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about 30% of people worldwide and can advance to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.